 |
|
|
||||||||||||||
 |
|
|
2010-Jul-22: Tethys Raises $33 Million
2010-Jul-01: PreDx® featured on CBS Interactive's Smartplanet
2010-Jun-24: Tethys Announces Issuance of Key Patent Relating to PreDx™ Diabetes Risk Score Test
2009-Nov-09: Tethys Bioscience Raises $25 Million in Series D Financing
2009-Aug-31: Personnel Additions and Promotions at Tethys Bioscience
2008-Nov-20: Tethys Bioscience Joins National Diabetes Goal
2008-Sep-17: Tethys Bioscience Announces Acquisition of Lipomics Technologies
2008-Jun-07: Tethys Bioscience Announces Expanded Availability of PreDx™ Diabetes Risk Test
2008-Jan-10: Tethys Bioscience Hits Key Milestones with Series C Funding, Opening of CLIA Laboratory
Jul 22, 2010
Tethys Raises $33 Million
Tethys Bioscience, Inc., announced today that the company has recently raised $33 million, comprising $23 million of venture financing and a $10 million working capital loan.
Jul 14, 2010
Diabetes Risk, on a Scale of 1 to 10
A new test is transforming the way some doctors diagnose and treat their patients.
(Technology Review)
Jul 1, 2010
PreDx® featured on CBS Interactive's Smartplanet
CBS Interactive smartplanet video segment focuses on the impact of the PreDx® Diabetes Risk Score on the physician and patient.
Jun 24, 2010
Tethys Announces Issuance of Key Patent Relating to PreDx™ Diabetes Risk Score Test
United States Patent and Trademark Office grants patent to Tethys. The patent is directed to the company's groundbreaking PreDx™ Diabetes Risk Score (DRS) test and relates to proprietary methods for assessing the risk of developing a diabetic condition.
Nov 9, 2009
Tethys Bioscience Raises $25 Million in Series D Financing
The financing round is led by aeris Capital with George Rehm taking a seat on the Tethys board.
Oct 20, 2009
Gazing into the Future
(Journal of Life Sciences, Fall 2009)